Westchester, Ill. — A study in the Nov. 1 issue of the journal Sleep is the first demonstration of a specific neurochemical abnormality in adults with primary insomnia, providing greater insight to ...

In a systematic review and meta-analysis, researchers compared and evaluated the effect differences of multiple acupuncture therapies for patients with primary insomnia. There is a low or very-low ...

Findings seen in as little as one month of treatment through 18 months of treatment. (HealthDay News) — Insomnia patients taking cannabis-based medicinal products report better quality sleep, ...

WASHINGTON, Sept. 25, 2025 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced the publication of an article titled "Melatonin agonist tasimelteon (HETLIOZ®) improves ...

Chronic insomnia may be caused by a number of factors, including lots of stress, sleep apnea, or acid reflux.

In many instances in clinical practice, education about the adverse effects of long-term hypnotic use has motivated a patient to discontinue medication. The adverse effects of benzodiazepine-like ...

In a recent study published in The Lancet, researchers compare the cost-effectiveness and clinical impact of nurse-delivered sleep restriction therapy with sleep hygiene for insomnia treatment. Study: ...

Inability to fall asleep at night can lead to serious health concerns — it's important to manage your insomnia and get a better night's rest. (Getty Images) Sleep is something you may take for granted ...

Please provide your email address to receive an email when new articles are posted on . Cognitive behavioral therapy offered via a telephone call improved sleep, fatigue and, “to a lesser degree,” ...

In the study, published on September 24, 2025 in PLOS One, HETLIOZ ® met its primary endpoint, demonstrating a mean improvement in latency to persistent sleep (LPS) from baseline to the average of ...